Filter by: patients
Home > Community Treatment Reports and Side Effects > Etravirine (TMC125) Treatment Report
What is Etravirine (TMC125)?

Etravirine, also known as TMC125, is a non-nucleoside reverse transcriptase inhibitor antiretroviral drug. It is used for HIV-1 infection in combination with at least two antiretroviral agents in treatment-experienced patients exhibiting viral replication with documented resistance agents.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 30 6 Efficacy_major Efficacy_cant_tell
AIDS (Acquired Immune Deficiency Syndrome) 2 0

See all 37 patients currently taking Etravirine (TMC125)

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 2
Mild
 0
None
 4

Commonly reported side effects, conditions, and hospitalizations associated with Etravirine (TMC125)

Diarrhea 1
Rash or skin problems 1
Headaches 1
Sickness 1
Fat deposits (xanthomas) 1

Reported Dosages

  daily 2 mg daily 2 other daily 4 mg daily 100 mg daily 200 mg daily 400 mg daily 500 mcg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 7 Number of Patients: 7 22 Number of Patients: 22 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Etravirine (TMC125) (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 2   Side effects too severe: 67%
Did not seem to work 1   Did not seem to work: 33%
Personal research 1   Personal research: 33%
Doctor's advice 1   Doctor's advice: 33%
Change in health plan coverage 1   Change in health plan coverage: 33%

See all 3 patients who’ve stopped taking Etravirine (TMC125)

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Etravirine (TMC125)

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Etravirine (TMC125)

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Etravirine (TMC125)

Always
 4 67%
Usually
 2 33%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Etravirine (TMC125)

Very
 1 17%
Somewhat
 1 17%
A little
 3 50%
Not at all
 1 17%

Cost

Paid out of pocket

Cost of Etravirine (TMC125)

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 4 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.